Skip to main content
Home

Breadcrumb

  1. Home
  2. Healthcare and Life Science

Healthcare and Life Science

5 December 2022

Klebsiella pneumoniae vaccines - time to reprioritize

This month VacZine Analytics, a UK-based strategic research publisher exclusively focused on vaccines and infectious diseases, releases a brand-new global forecast of new Klebsiella pneumoniae vaccines. ...

2 December 2022

International Day of Persons with Disabilities

International Day of Persons with Disabilities - an annual campaign aiming to join communities together to support people with disabilities and create a future for them where they experience equal opportunities and face no barriers in all aspects of their lives including employment. The...

6 December 2022

Webcasting Plan B

“We pay you for when it goes wrong not for when it goes right” Roy Shepard executive producer explains why you need an experienced webcasting crew and always have a plan B. ...

2 December 2022

South Africa expansion delivers growth opportunities for Biocair

Biocair has invested heavily in the expansion of its South Africa operation with the opening of two new offices. ...

1 December 2022

Life-saving ambulance service marks birthday

A life-saving service for critically ill and injured hospital patients celebrates its first birthday today. ...

1 December 2022

Cresset CEO’s end of year message 2022

As we near the end of another year, Dr Robert Scoffin, CEO of Cresset, reflects on the events of 2022 ...

30 November 2022

AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy

Acquisition provides access to next-generation T-cell receptor therapies with promising potential for targeting solid tumours. ...

30 November 2022

Metrion Biosciences invests in new High Throughput Screening capability and expanded facilities

Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the launch of its High Throughput Screening (HTS) capability, as well as the expansion of its state-of-the-art lab and office facilities. Scott Maidment has ...

29 November 2022

Gyros Protein Technologies adds Gyrolab® Biomarker Kits to expand range of ready-to-use kits and reagents

Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, today introduced Gyrolab® Human Cytokine Kit Reagents, the first in a range of new biomarker kits.  These include five single analyte biom...

23 June 2022

Biocair develops dedicated team for cell and gene therapy logistics

Biocair has invested heavily in the creation of a specialist logistics team to meet the complex needs of the rapidly expanding cell and gene therapy sector. ...

Pagination

  • First page «
  • Previous page ‹‹
  • …
  • Page 227
  • Page 228
  • Current page 229
  • Page 230
  • Page 231
  • …
  • Next page ››
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS